<DOC>
	<DOCNO>NCT00793468</DOCNO>
	<brief_summary>The purpose study determine effect GSK598809 compare placebo prevent recently-quit smoker go back smoking .</brief_summary>
	<brief_title>Relapse Prevention Study Newly Abstinent Smokers</brief_title>
	<detailed_description>The primary objective study evaluate efficacy GSK598809 compare placebo prevention relapse smoke recently abstinent smoker . Subjects meet eligibility criterion enter 4-week open label treatment period receive nicotine replacement therapy ( NRT ) . Subjects achieve least one week abstinence last week open label treatment period randomize either GSK598809 placebo double-blind treatment period follow another 12 week .</detailed_description>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<criteria>smoke least 10 cigarette day least 2 year multiple previous attempt quit smoke relapse smoking . generally healthy use smokeless tobacco type try quit medicine . abuse alcohol drug certain emotional problem treat medication pregnant breast feeding female</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>nicotine dependence</keyword>
	<keyword>smoking</keyword>
	<keyword>pharmacological treatment</keyword>
	<keyword>relapse prevention</keyword>
</DOC>